Sanofi supply chain backup in Brazil costs big bucks; FDA facility fees to rise;

> A major supply chain backup in Brazil cost French drugmaker Sanofi ($SNY) €212 million in lost sales and other costs in its last quarter. Story

> A 63-year-old Utah man will do a year in federal prison after being convicted of illegally obtaining and selling prescription drugs like Botox and Aranesp in the U.S. Release

> FDA facility fees on plants producing generic drugs are going up more than $40,000 for 2014 and more than $8,000 for API facilities. Report

> Nexus Pharmaceuticals has recalled two lots of Benztropine Mesylate Injection, USP, 2 mg/2 mL (1 mg/mL) in 2-mL single-dose vials manufactured for it by Allergy Laboratories after reports of visible particulate matter in the vials. Notice

> Drug distributor Cardinal Health wrote off all of the goodwill value, $829 million, of its nuclear medicine manufacturing business in the fourth quarter because of receding business for some of its products. Report

> Sanofi ($SNY) intends to use a wind turbine to generate some of its electricity for a new plant in Ankleshwar in Gujarat, India. Report

And Finally... Fifty jobs have been lost after the the pharma company Euticals went into liquidation and its plant in Sandycroft, Deeside, Wales, closed after authorities last fall found isosorbide dinitrate at the plant and decided it was potentially harmful to surrounding neighborhoods. Story

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.